In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.
[audio:https://www.audiomedica.com/podcasting/aha2005/Milton_Packer.mp3]
Audio Journal of Cardiovascular Medicine: September 5th 2006 5 Sep, 2006 Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI 5 Nov, 2007 Audio Journal of Cardiovascular Medicine 12.1, January 2006 10 Jan, 2006 Rapid Genotype Assay for Individualized Warfarin Dosing 25 Mar, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014